A pneumolysin-based agglutination test which allows an easy, rapid, cost-effective, and accurate (100% specific and 95% sensitive) discrimination between pneumococci and other related human and animal pathogenic bacterial strains has been assayed.
MATERIALS AND METHODS
Antigen. Recombinant pneumolysin-a pTrc 99A construction-was expressed in Escherichia coli JM105 and purified from cell lysates by fast protein liquid chromatography with a HiLoad 16/10 phenyl-Sepharose hydrophobic column (Pharmacia), essentially as described elsewhere (16) .
Rabbit polyclonal antiserum production. Purified pneumolysin was suspended in 10 mM phosphate-buffered saline, pH 7.3, and emulsified 1:1 in incomplete Freund's adjuvant (Sigma). A New Zealand rabbit was intramuscularly injected at 2-week intervals with 1 ml of immunogen emulsion (5) . Immunizations comprised 25 g, 50 g, 100 g (two doses), and 1 mg (eight doses) of purified pneumolysin. Two weeks after the last immunization, the animal was anesthetized and subjected to exsanguination by cardiac puncture (6) .
The immunoglobulin G (IgG) fraction of the antiserum was purified after ammonium sulfate precipitation followed by affinity chromatography with protein A-Sepharose (Pharmacia) (3) .
Preparation of sensitized staphylococci. Two-milliliter aliquots of this IgG were extensively absorbed with sonicates of E. coli JM105 and applied to 1 ml of 10% (vol/vol) suspensions of activated Staphylococcus aureus Cowan 1 (ATCC 12598) as described by Kronwall (15) . Staphylococci sensitized with normal rabbit IgG reagent-grade fractions (Sigma), absorbed as described above, were similarly prepared to be used as negative controls. To make agglutination more evident, 3 ml of sensitized staphylococcal suspensions was counterstained with 900 l of the basic blue solution, Colorante 2 (Tinción rápida Grifols; Diagnostic Grifols, S.A., Parets del Vallès, Barcelona, Spain).
Bacterial specimens. The present study included (i) a few reference strains of the family Enterobacteriaceae; (ii) nonpneumococcal lysates from reference bacterial strains producing pneumolysin-related toxins, including six different clinical isolates of Clostridium perfringens; (iii) beta-hemolytic streptococci (Streptococcus pyogenes, Streptococcus equi subsp. equi, and Streptococcus equisimilis); (iv) reference viridans streptococci (21) (Streptococcus anginosus, Streptococcus bovis, Streptococcus mitis, Streptococcus salivarius, and Streptococcus sanguis) and 50 unselected clinical isolates of this group (47 were recovered from sputa, 2 were recovered from musculoskeletal wounds, and 1 was recovered from a blood culture); (v) several other streptococci; (vi) 22 reference pneumococcal strains belonging to different serotypes; (vii) 10 nontypeable pneumococcal isolates from the Laboratorio de Referencia de Neumococos, Centro Nacional de Microbiología, Madrid, Spain (they were classified as pneumococci based on their sensitivity to optochin and bile solubility); (viii) 20 atypical pneumococcal isolates also received from the Laboratorio de Referencia de Neumococos (these were resistant to optochin and/or insoluble in deoxycholate but positive by hybridization with the specific DNA probe pCE3 [8, 9] ); and (ix) 22 pneumococcal isolates recovered from 6-year-old children considered to be healthy carriers (their classification as pneumococci was based on their sensitivity to optochin and bile solubility as described above). The hemolytic activity of lysates from thiolactivated cytolysin-producing strains was also assayed (24) .
Bacterial isolates under investigation were grown as lawns on blood agar plates at 37°C for 24 h. Thereafter, bacterial suspensions were prepared in phosphatebuffered saline containing 0.05% Triton X-100, pH 7.3, and spectrophotometrically standardized to an optical density of 2 at 625 nm. These bacterial suspensions were then incubated at 37°C for 30 min. This is a gentle treatment which lyses pneumococci and allows the release of pneumolysin. Lysates-suspensions were afterwards spun down at 15,000 ϫ g for 5 min in a bench top Eppendorf 5415 C centrifuge.
Agglutination tests. The assays were carried out essentially as described previously (25) , with minor adaptations. Agglutination tests were performed on a smooth white glazed surface. Twenty-five microliters of the final bacterial supernatants was mixed with 25 l of sensitized staphylococci, covering an elliptical area (approximately 2 by 3.5 cm) with the help of a disposable stick. The mixture was then rocked back and forth by hand. Results were clearly apparent with the naked eye under the regular fluorescent light of the laboratory. A test was considered positive when agglutination occurred within 3 min of mixing the staphylococcal suspensions and the test samples.
RESULTS AND DISCUSSION
Agglutination results are shown in Table 1 . Lysates from the unselected clinical isolates of the viridans group usually presented a slow-developing weak agglutination which was also visible with the negative control staphylococci; these phenomena were never observed with the other strains tested. Under the assayed conditions, only pneumococcal isolates produced positive results with the antipneumolysin-sensitized staphylococci. This agglutination was generally strong and readable in 90 s. Lysates from S. pneumoniae 993 ATCC 33400 type 1 and from three atypical pneumococcal isolates did not induce agglutination; the lysate from the reference strain was partially hemolytic, whereas the other three were not hemolytic at all. When lysates from highly concentrated bacterial suspensions of these isolates were retested, agglutination results remained negative. Supposed producers of listeriolysin O (Listeria monocytogenes), ivanolysin (Listeria ivanovii), perfringolysin O (C. perfringens), suilysin (S. suis), or streptolysin O (S. pyogenes) did not elicit agglutination. What is more, amounts as low as 5 ng of purified pneumolysin induced agglutination, whereas 1 g of commercially available streptolysin O or alpha-hemolysin from S. aureus (Sigma), or purified alpha-hemolysin from E. coli, did not.
The absorbed pneumolysin-specific rabbit IgG preparation developed an intense single band of 53 kDa when assayed by Western blotting against 500 ng of purified pneumolysin but a barely visible one against streptolysin O. Five randomly selected pneumococcal lysates showed a band smear with a major band of 53 kDa; a similar pattern of a few fainter bands was visible when lysates from three strains of L. monocytogenes, one of L. ivanovii, three of C. perfringens, one of S. suis, and three of S. pyogenes were tested. The above-mentioned agglutination-negative lysates presented only faint bands when the Western blot was developed by using an enhanced chemiluminescence substrate (peroxidase; Boehringer Mannheim).
Our observations show that this pneumolysin-based test is (i) an easy, cost-effective, and rapid method for the identification of pneumococcal isolates (sample preparation does not take more than 45 min, nor does it require any additional routine laboratory equipment; agglutination results are read in less than 3 min); (ii) 100% specific, in spite of the observed cross-reactions between the antipneumolysin polyclonal serum that we used and the antigenically related toxins; and (iii) 95% sensitive. Pneumococcal strains seem to produce variable amounts of pneumolysin, as judged by their hemolytic activities (1, 13) ; a detailed analysis of the extent of pneumolysin production by pneumococcal isolates is lacking. Those agglutinationnegative lysates seem to correspond to low-pneumolysin-producing isolates as hemolysis and enhanced chemiluminescence Western blot analyses have shown. Overall, we conclude that this pneumolysin-mediated agglutination enables an easy and accurate discrimination between pneumococci and other human and animal pathogenic bacterial strains and is therefore of high microbiological diagnostic value; in an improved format, its sensitivity could be even higher than that reported in this paper and could also be applied to the detection of pneumolysin in biological samples in order to speed up the diagnosis of pneumococcal infections.
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